HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA
INBC 2025

Ollier’s disease with grade II astrocytoma case report and brief review of astrocytoma

Speaker at Neurology Conferences - Hunter Slosser
Kansas City University, United States
Title : Ollier’s disease with grade II astrocytoma case report and brief review of astrocytoma

Abstract:

Ollier’s disease is a dysplasia of cartilage characterized by multiple enchondromas. Previous literature did not observe the concurrence of Ollier’s disease and gliomas, however, the presence of these two comorbidities is now becoming evident. In patients with Ollier’s disease, isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) mutations were shown to be a predisposing factor to the development of astrocytomas in conjunction with subsequent mutations in ATP-dependent helicase ATRX (ATRX) and tumor protein p53 (TP53). We present a case report of a 21-year-old male with an adolescent diagnosis of Ollier’s disease who developed a grade II astrocytoma in early adulthood. The patient presented to the emergency room with seizures, was given anti-seizure medication, and later underwent chemotherapy and resection of the astrocytomas. A literature review showed 12 additional patients diagnosed with Ollier’s disease who were subsequently diagnosed with a grade II astrocytoma later in life. We conclude this case report with a discussion of the genetics of Ollier’s disease and emphasize the importance of performing routine cranial magnetic resonance imaging (MRI) in these patients.

Biography:

Hunter Slosser, BS is a medical student at Kansas City University with a strong interest in neuroscience and medical genetics. His research focuses on pharmacogenomics and rare neurological conditions, including Ollier’s disease and its association with astrocytomas. He co-authored a case report highlighting the genetic links between isocitrate dehydrogenase mutations and tumor development. With experience as a Genetic Counselor Assistant and a Teaching Assistant in Neuroscience, Hunter is passionate about advancing precision medicine and understanding the genetic basis of neurological disorders.

Watsapp